SCHEMBL14264656

SCHEMBL14264656

Cc1cc(Cl)cc(C(=O)Nc2cc(S(=O)(=O)c3ccc(Cl)cc3)ccc2Cl)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 1.00
BCL2L1 Q07817 3/20 0.76
LMNA P02545 3/20 0.54
POLB P06746 1/20 0.54
ALDH1A1 P00352 5/20 0.52
CYP2C9 P11712 1/20 0.48
CRHBP P24387 2/20 0.47
CRHR2 Q13324 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 2/20 0.47
SLC16A1 P53985 1/20 0.46
PTGS1 P23219 1/20 0.44
TBXAS1 P24557 1/20 0.44
MAPK1 P28482 1/20 0.44
PTGS2 P35354 1/20 0.44
MAPK14 Q16539 1/20 0.44
NPC1 O15118 1/20 0.44
SLC10A2 Q12908 1/20 0.43
SLC10A1 Q14973 1/20 0.43
SLC10A6 Q3KNW5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13242107 0.92 BCL2 (0.85) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL29377616 0.87 BCL2L1 (0.77) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL4304061 0.87 BCL2L1 (0.77) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL14163444 0.86 BCL2L1 (1.00) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL13242106 0.84 BCL2 (0.72) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL15313811 0.83 BCL2 (0.71) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL5150417 0.81 BCL2L1 (0.69) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL15313812 0.81 BCL2L1 (0.68) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL157069 0.78 BCL2L1 (0.77) BCL2BCL2L1LMNAPOLBALDH1A1
SCHEMBL15313855 0.76 BCL2L1 (0.61) BCL2BCL2L1LMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058322-A1 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-03-06 US disclosed
US-20080058322-A1 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058322-A1 Small molecule inhibitors targeted at Bcl-2 BCL2, BCL2L1, BCL2L2 BCL2 1/4885BCL2L1 2/4885LMNA 3856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.